Fentanyl transdermal system vs oxycodone for chronic pain

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1339, 2002-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain

By Kornick C.A. Santiago-Palma J. Moryl N. Payne R. Obbens E.A.M.T.

Drug Safety, Vol. 26, Iss. 13, 2003-01 ,pp. : 951-973

Adis International

Access to resources Recommend Favorite

Fentanyl vs oxycodone study results highly questionable

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 379, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Transdermal fentanyl transforms pain in osteoarthritis

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Transdermal Fentanyl: An Updated Review of its Pharmacological Properties and Therapeutic Efficacy in Chronic Cancer Pain Control

By Muijsers R.B.R. Wagstaff A.J.

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2289-2307

Adis International

Access to resources Recommend Favorite

Transdermal Matrix Fentanyl Membrane Patch (Matrifen®): In Severe Cancer-Related Chronic Pain

By Hair Philip I. Keating Gillian M. McKeage Kate

Drugs, Vol. 68, Iss. 14, 2008-01 ,pp. : 2001-2009

Adis International

Access to resources Recommend Favorite